The Spatial and Temporal Expression Patterns of Integrin α9β1 and One of Its Ligands, the EIIIA Segment of Fibronectin, in Cutaneous Wound Healing  by Singh, Purva et al.
The Spatial and Temporal Expression Patterns of Integrin a9b1
and One of Its Ligands, the EIIIA Segment of Fibronectin,
in Cutaneous Wound Healing
Purva Singh,1 Corinne L. Reimer,w1 John H. Peters,zy Mary Ann Stepp,z Richard O. Hynes,#
and Livingston Van De Water
Center for Cell Biology and Cancer Research, Albany Medical College, Albany, New York, USA; wDepartment of Cancer Biology, Millennium Pharmaceuticals,
Cambridge, Massachusetts, USA; zDepartment of Internal Medicine, University of California-Davis, School of Medicine, Davis, California, USA; yThe Sacramento
VA Medical Center, VA Northern California Health Care System, Mather, California, USA; zDepartments of Anatomy and Cell Biology and Ophthalmology, George
Washington University Medical Center, Washington, District of Columbia, USA; #Howard Hughes Medical Institute and Center for Cancer Research, Department of
Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
The ﬁbronectins (FN) comprise a family of adhesive extracellular matrix proteins thought to mediate important
functions in cutaneous wounds. Plasma ﬁbronectin (pFN) extravasates for days from intact hyperpermeable ves-
sels following injury whereas mRNAs encoding the cellular ﬁbronectins (cFN) that include two segments, termed
EIIIA (EDA) and EIIIB (EDB), are expressed by wound cells. Wounds in mice null for pFN appear to heal normally
whereas those in EIIIA null mice exhibit defects, suggesting that cFN may play a role when pFN is missing. Integrin
a9b1, a receptor for several extracellular matrix proteins as well as the EIIIA segment, is expressed normally in the
basal layer of squamous epithelia. We report results from immunohistochemistry on healing wounds demonstrat-
ing that EIIIA-containing cFN are deposited abundantly but transiently from day 4 to 7 whereas EIIIB-containing cFN
persist at least through day 14. Elevated expression of a9b1 is seen in basal and suprabasal epidermal keratin-
ocytes in wounds. The spatial expression patterns of cFN and a9b1 are distinct, but overlap in the dermal–
epidermal junction, and both are expressed contemporaneously. These observations suggest a role for a9b1–EIIIA
interactions in wound keratinocyte function.
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A central feature of the wound site is the assembly of a
‘‘provisional’’ extracellular matrix composed of plasma pro-
teins, including clotted fibrin and plasma fibronectin (pFN).
This provisional matrix arises initially as a result of hem-
orrhage but is maintained for some days by plasma extra-
vasation mediated by endothelial cells in the post-capillary
venules (Brown et al, 1992). During healing, this provisional
matrix is gradually replaced by synthesis of extracellu-
lar matrix proteins, including variants of fibronectin (FN)
(ffrench-Constant et al, 1989; Brown et al, 1993; Serini et al,
1998; Sakai et al, 2001).
The FN are a family of extracellular matrix proteins gen-
erated by alternative splicing in three segments termed EIIIA
(or EDA), EIIIB (EDB), and V (IIICS) (Hynes, 1990). pFN lacks
the EIIIA and EIIIB segments and the expression of FN that
include these spliced segments tends to be quite restricted
in adults. By contrast, the EIIIA and EIIIB segments are
prominent in embryos, exhibiting characteristic patterns in
specific developing tissues suggesting that each FN variant
may serve important functions. Two integrins, a9b1 and
a4b1, bind the EIIIA segment of FN (Liao et al, 2002),
whereas no receptors have been identified for the EIIIB
segment.
Although the fibrin–FN-rich provisional matrix is promi-
nent at sites of injury, mice made conditionally null for pFN
heal cutaneous wounds normally, suggesting that locally
produced EIIIA- or EIIIB-containing FN may function in the
absence of extravasated pFN (Sakai et al, 2001). Mice that
are lacking the EIIIB segment are viable and show no ob-
vious defects during rib fracture repair but exhibit subtle
difference in fibronectin matrix assembly (Fukuda et al,
2002). Mice null for EIIIA segment are reported to show
defects in reorganization of the dermal–epidermal junction
following injury, raising the possibility that EIIIAþFN may
influence keratinocyte function during wound healing (Muro
et al, 2003).
Following injury, epidermal keratinocytes migrate from
the edge of the wound over a matrix that likely includes
remnants of dermal collagen as well as a newly synthesized
provisional basement membrane rich in laminin-5 (LN-5)
deposited by leading edge keratinocytes (Nguyen et al,
2000; Kubo et al, 2001). Integrin b1 family members are
critical to keratinocyte adhesion, epithelial architecture, and
migration during normal cutaneous wound healing (Ragha-
van et al, 2000; Grose et al, 2002). Normal skin keratinocytes1Contributed equally to this work.
Abbreviations: cFN, cellular fibronectin; EIIIA (EDA), EIIIB (EDB),
and V (IIICS), three segments of fibronectin generated by alternate
splicing; FN, fibronectins; pFN, plasma fibronectin
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express integrins including a2b1, a3b1, a5b1, a6b4, avb5,
and avb6. Integrins a2b1 and a5b1 are upregulated fol-
lowing injury and are found in basal and suprabasal lay-
ers; however, a3b1 and a6b4 are also upregulated, but are
confined to basal keratinocytes (Larjava et al, 1993; DiP-
ersio et al, 1997; Nguyen et al, 2000). Integrin a9b1 is ex-
pressed by basal keratinocytes in normal skin (Palmer et al,
1993; Stepp et al, 2002). The expression pattern of a9b1
during cutaneous wound healing, however, remains unclear.
Integrin a9b1 is normally expressed in airway epithelial
cells, the basal layer of squamous epithelia, smooth muscle,
skeletal muscle, neutrophils, and hepatocytes (Palmer et al,
1993). Within 6–12 d of birth, null mice die with defects in
the lymphatic system (Huang et al, 2000). Ligands for a9b1
include tenascin-C, osteopontin, vascular cell adhesion
molecule-1 (VCAM-1), von Willebrand factor, tissue trans-
glutaminase, ADAMs-12 and 15, and the EIIIA segment of
FN (Liao et al, 2002; Stepp et al, 2002, and references con-
tained therein). Increased expression of a9b1 in keratin-
ocytes following injury has been reported in oral mucosal,
corneal, and skin wounds (Stepp and Zhu, 1997; Hakkinen
et al, 2000; Stepp et al, 2002; Pal-Ghosh et al, 2004). Al-
though a9b1 is upregulated in corneal epidermal wounds
during migration and re-stratification (Stepp and Zhu, 1997;
Stepp et al, 2002), normal re-epithelialization and expres-
sion of a9b1 occurs in tenascin-C-deficient mice, suggest-
ing that ligands other than, or in addition to, tenascin-C may
bind to a9b1 during corneal healing (Iglesia et al, 2000).
A close examination of the expression of both EIIIA- and
EIIIB-containing forms of FN, as well as a9b1 integrin, would
provide clues about their functions during wound healing.
We report here that keratinocytes express a9b1 during
wound healing and that myofibroblasts do not. Our data
support a model in which keratinocyte a9b1 serves multiple
functions. These include EIIIA-independent functions, as for
suprabasal keratinocytes that do not encounter EIIIA-con-
taining FN, as well as EIIIA-dependent functions, and as for
basal and migrating keratinocytes, which likely interact with
EIIIA at the dermal–epidermal junction.
Results
FN in normal and wounded skin Prior work from our lab-
oratories demonstrated that FN mRNAs were expressed at
low levels in unwounded skin (ffrench-Constant et al, 1989).
Using antibodies reactive with either the V95 (IP73) region or
a constant region of rat FN (BR5.3), we observed that nor-
mal rat skin contained low levels of FN protein (Fig 1a).
Small blood vessels within the papillary dermis were pos-
itively stained, however. We next delineated the spatial ar-
rangement of total FN in healing wounds (Fig 1b–d ).
Following wounding, intense staining for total FN was ob-
served in the wound bed at 4, 7, and 14 d (‘‘w’’ in Fig 1b–d );
little staining was observed in the adjacent unwounded de-
rmis and none was evident in the overlying, regenerated
epidermis (‘‘e’’ in Fig 1c, d). Thus, we observe a striking
increase in the total amount of FN deposited in healing
wounds relative to normal skin.
When immunostaining was performed with antibodies
specific to the EIIIA and EIIIB segments, we observed no
significant staining in normal skin (Fig 2a, e). By 4 d follow-
ing wounding, however, staining for both the EIIIA and EIIIB
segments was observed in granulation tissue (Fig 2b, f ).
Staining for both segments increased in the granulation tis-
sue at 7 d (Fig 2c, g) and exhibited a fibrillar pattern (inset,
Fig 2g). Importantly, staining for EIIIB remained elevated
through day 14 following wounding (Fig 2h) whereas stain-
ing for EIIIA was strikingly reduced (Fig 2d ). Moreover,
staining for smooth muscle cell (SMC) a-actin followed ki-
netics identical to those of the EIIIA segment with bright
staining of myofibroblasts at day 7 and strikingly reduced
staining at day 14 (not shown). Comparable staining was
observed with different monoclonal antibodies (mAb) IST-9
(Fig 2a–d ) and 3E2, as well as a goat polyclonal anti-EIIIA
antibody (not shown). Arterioles, but not venules within the
connective tissue subjacent to the panniculus carnosus,
were also immunopositive for EIIIAþFN during the interval
from 4 to 10 d (not shown). The epidermis was not stained
at any time point with any antibody to FN, consistent with
our analysis of FN mRNAs by in situ hybridization (ffrench-
Constant et al, 1989). These results demonstrate that a
temporal switch occurs in the composition of the granula-
tion tissue between 7 and 14 d, with selective loss of the
EIIIA segment, but retention of the EIIIB segment at 14 d.
Temporal pattern of integrin a9 expression in the epi-
dermal keratinocytes migrating over the wound bed The
transient but prominent expression of EIIIAþFN in cutane-
ous wounds (Fig 2a–d) prompted us to determine the
Figure 1
Analysis of fibronectin (FN) deposition in normal and wounded skin by immunohistochemistry. Cryostat sections of normal rat skin were
reacted with antibodies to the V95 (panel a), or monoclonal antibody (mAb) BR5.3 (panels b–d ). Excisional rat cutaneous wounds (4 mm diameter)
were harvested at intervals of 4, 7, or 14 d (panels b–d ) post-wounding. Sections are oriented with epidermis (‘‘e’’) at the top. FN is present in the
wound bed (‘‘w’’) following injury and persists through day 14 (d ). Magnification: scale bar¼50 mm.
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spatiotemporal expression pattern of one of its receptors,
a9b1, in skin following injury. Earlier work established that
a4b1 is expressed prominently by inflammatory cells, but
also by fibroblasts and endothelial cells, and we did not
study this further here (Massia and Hubbell, 1992; Gailit
et al, 1993). We performed immunohistochemistry with a
rabbit antibody that reacts with a9b1 on tissues harvested
at intervals of 1–14 d (Fig 3). Images were obtained with
equivalent exposure times. Increased levels of a9 expres-
sion were evident as early as day 1 post-injury in the basal
and adjacent suprabasal layers of keratinocytes at the
wound edge. The leading edge of keratinocytes migrating
over the wound bed was brightly labeled with antibodies to
a9 and staining was more intense at days 2 and 4 compared
to day 1 post-wounding. By day 7, migrating keratinocytes
had closed the wound and a9 staining peaked and was
expressed in basal and suprabasal layers (Fig 3d ). By days
10 and 14, we observed a marked decrease in a9 staining in
the suprabasal keratinocytes. In contrast to the staining di-
rectly over the wound bed, staining in the epidermis at a
distance from the wound remained confined to the basal
layer of keratinocytes as it is in normal epidermis (not
shown).
Expression of integrin a9 in arterioles and skeletal mus-
cle cells We also noted a9b1 staining within the wound bed
(Fig 3d ). It was previously reported that blood vessels were
positive for a9 in the granulation tissue of oral mucosa
wounds (Hakkinen et al, 2000). To test whether or not blood
vessels expressed a9 during cutaneous wound healing, we
Figure 2
Temporal pattern of EIIIA and EIIIBþFN (fibronectin) in healing wounds. Cryostat sections were reacted with mouse monoclonal anti-EIIIA (a–d )
or rabbit anti-EIIIB antibodies (e–h). Normal rat skin (panels a, e) or excisional cutaneous wounds (panels b–d, f–h) were harvested from rats at
intervals of 4, 7, or 14 d post-wounding. In normal skin, EIIIA is present in the intima of some arterioles within the panniculus carnosus (inset, a); little
to no staining for EIIIB was observed in vessels (inset, panel e). EIIIA and EIIIB staining is prominent between days 4 and 7. Staining has fibrillar
appearance (panel g, inset). Little staining was observed in flanking, unwounded dermis ( in panel h). Staining for EIIIB persisted whereas EIIIA-
decreased markedly between days 7 and 14 (cf. panels d with h). Wound bed denoted by ‘‘w’’. Magnification: scale bar¼ 50 mm, inset bar¼ 10 mm.
Figure 3
Spatiotemporal expression of a9 in the
epidermal keratinocytes migrating over
the wound bed. Excisional mouse cuta-
neous wounds were harvested at intervals
of 1, 2, 4, 7, 10, and 14 d post-wounding.
Harvested wounds were oriented with ep-
idermis on top and panniculus carnosus
below. Note progressive increase in a9b1
expression at day 1 through day 7 in basal
(arrow) and suprabasal keratinocytes (‘‘s’’),
over the wound bed (‘‘w’’). By contrast,
a marked decrease in a9 expression is
evident 10 and 14 d (panels e, f ). Mag-
nification: scale bar¼50 mm.
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performed immunohistochemistry on 7-d mouse wounds, a
time marked by granulation tissue formation with prominent
blood vessels. Tubular structures with the appearance of
blood vessels were positive for a9 in granulation tissue and
in the adjacent dermis. When we carried out double-label
immunostaining with rabbit anti-a9 antibodies and either rat
anti-CD31, or anti-SMCa, however, we observed that a9b1
did not co-localize appreciably with either marker in the tu-
bular structure within granulation tissue. When we exam-
ined blood vessels in adjacent dermis, we observed that
anti-CD31 stained the endothelial layer, whereas a9 local-
ized primarily to the medial layer of blood vessels (Fig 4a, b).
Selected skeletal muscle cells in the injured panniculus
carnosus also stained positively for a9 at day 4 (not shown)
and at day 7 (Fig 4c) post-injury. We observed that not all
skeletal muscle cells express a9, but those at the end most
proximal to injury were preferentially labeled.
Discussion
Alternative splicing of FN provides an efficient mechanism
for regulating the expression of function-specific isoforms
following tissue injury. Results reported here provide new
data that reveal a distinct temporal pattern of FN splicing
and protein deposition for the EIIIA and EIIIB segments in
wounds. The EIIIA segment is deposited in the wound ECM
between days 4 and 7 (Fig 2) and this pattern coincides
temporally with the expression of a9b1 by keratinocytes
(Fig 3). This integrin is expressed by basal keratinocytes in
normal skin, and its expression is dramatically upregulated in
both basal and suprabasal cells over and in close proximity
to the wound (Fig 3). Although EIIIA-containing FN are de-
posited throughout the granulation tissue concomitant with
the expression of SMC a-actin, they are also abundant in
the dermal–epithelial zone through which keratinocytes mi-
grate (Fig 2). Despite strong EIIIA–FN staining in the gran-
ulation tissue, a9b1 is not detectable in myofibroblasts. Our
data suggest that keratinocyte–a9b1 interactions with the
EIIIA segment of FN may be important to keratinocyte
function during re-epithelialization.
In normal adult skin, low levels of FN are detected and
these FN are largely devoid of the EIIIA or EIIIB segments
(Figs 1 and 2a, e). Immediately after wounding, the extra-
cellular matrix changes dramatically. Frank hemorrhage and
prolonged blood plasma extravasation over several days
result in the deposition of plasma proteins, such as pFN,
fibrinogen, and vitronectin into the ‘‘provisional matrix’’
within the viable tissue of the wound bed (Grinnell et al,
1981; Clark et al, 1982). By 1–2 d after injury, wound ma-
crophages contain increased levels of FN mRNAs that in-
clude the EIIIA and EIIIB segments (Brown et al, 1993) and
by 4 d these cFN are deposited in the wound matrix (Fig 2).
This temporal pattern of FN splicing occurs in other types of
injury indicating that a general pattern exists in which pFN
that lacks the EIIIA and EIIIB segments is deposited prior to
‘‘cellular’’ FN that includes these segments suggesting that
the temporal pattern of FN variant expression has functional
consequences for individual cell types in distinct repair
settings.
Our observation of a concurrent appearance and cessa-
tion of EIIIA and SMC a-actin expression during granulation
tissue formation is consistent with observations that EIIIA
may be necessary for myofibroblast differentiation (Serini
et al, 1998). Although we previously determined that a4b1
and a9b1 integrins function as receptors for the EIIIA seg-
ment (Liao et al, 2002), we show here that a9b1 is not de-
tected in myofibroblasts. Indeed, we find that a9b1 is not
expressed by cultured fibroblasts and myofibroblasts,
whereas a4b1 is, when assayed by flow cytometry (Phillips
and Van De Water, unpublished observations). By contrast,
vascular smooth muscle cells do express a9b1 and this
expression is markedly upregulated in some, but not all,
arterioles in healing wounds as well as by injured skeletal
muscle cells (Fig 4). Our observation that skeletal myofibrils
within the panniculus carnosus express a9b1 at their injured
ends (Fig 4) also suggests a potential role in cell fusion.
What is the potential importance of the concurrent ex-
pression of EIIIA and a9b1 during tissue repair? There are
several ligands for a9b1 in addition to the EIIIA segment. Of
these, osteopontin is present deep in the wound and not
adjacent to keratinocytes (Liaw et al, 1998). VCAM-1 is ex-
pressed by endothelial cells (Taooka et al, 1999). Tenascin-
C is prominently expressed in a pattern similar to the one for
EIIIA-containing FN reported here (Mackie et al, 1988; Ha-
kkinen et al, 2000). Interestingly, tenascin-C null mice heal
normally suggesting that other ligands for a9b1 may func-
tion in the absence of tenascin-C (Iglesia et al, 2000). EIIIA–
FN are expressed in a temporal pattern that is maximal
between days 4 and 7 and in a spatial pattern that overlaps
with keratinocyte a9b1 in the dermal–epidermal junction
(Figs 2 and 3). Although moderate levels of keratinocyte
Figure 4
Expression pattern of a9 in blood ves-
sels and skeletal muscle cells. Double
label immunostaining was performed on
cryostat sections of 7 day wounds using
rabbit anti-a9 antibody (a–c), and either rat
anti-CD31 (a), mouse anti-SMC a-actin (b),
or phalloidin (c). Fields shown in panels a
and b represent dermis adjacent to gran-
ulation tissue. Note that medial layer of
arterioles labeled with a9 and SMC a-actin
is observed in many but not all blood ves-
sels (b). Integrin a9 did not co-localize sig-
nificantly with CD31-positive endothelial
cells (a). Selected skeletal muscle cells
adjacent at the edge of injured panniculus carnosus stain for a9 (c). Arrow denotes blood vessel staining (a, b) and skeletal muscle cells (c). Mag-
nification: scale bar¼ 50 mm.
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a9b1 are observed in the basal layer of normal epidermis,
a9b1 expression is upregulated in keratinocytes at sites
immediately over the injury. Because keratinocytes do not
express a4b1 (Kubo et al, 2001), our data support a hy-
pothesis in which EIIIA, along with tenascin-C, interac-
tions with a9b1 regulate keratinocyte functions important
to re-epithelialization such as migration, differentiation or
proliferation.
Our data also support a model in which keratinocyte
a9b1 serves multiple functions. These include EIIIA-de-
pendent functions such as basal keratinocytes that likely
interact with EIIIA at the dermal–epidermal junction and may
modulate re-epithelialization. They also include EIIIA-inde-
pendent functions, as for suprabasal keratinocytes that do
not encounter EIIIA-containing FN. Because the a9b1 null
mouse is perinatally lethal, these hypothesized roles have
not been tested (Huang et al, 2000). Integrin a9b1 is ex-
pressed during murine embryogenesis at a time in which
epithelial stratification occurs and eyelid fusion takes place,
and a9b1 is found at sites and times where leading edges of
epithelial sheets are merging during the closure of corneal
wounds (Wang et al, 1995; Pal-Ghosh et al, 2004). Our data
are consistent with these observations and show that ele-
vated expression of a9 is seen in suprabasal and basal
keratinocytes and persists until the migrating epidermis
merges together from both ends by day 7 (Fig 3); beyond
this day, a9 expression decreases markedly.
Materials and Methods
Materials A mouse mAb, BR5.3, reacts with all forms of FN (Pe-
ters and Hynes, 1996; Peters et al, 1996). Antibodies to EIIIA in-
clude mAb to rat and human EIIIA (clone IST-9, Accurate Scientific,
Westbury, New York; clone 3E2, Sigma Chemical, St Louis, Mis-
souri). IP73, IP153, and IP264 are polyclonal antibodies raised to
the V95 segment, to an EIIIA-derived synthetic peptide, and to an
EIIIB-GST fusion peptide, respectively (Peters and Hynes, 1996;
Peters et al, 1996). Rabbit anti-a9 antibodies were raised against a
synthetic peptide (Iglesia et al, 2000). Anti-SMC a-actin mAb, clone
1A4, was purchased from Sigma Chemical. Mouse anti-CD31
(MEC13.3, BD Pharmingen, San Diego, California) was used as an
endothelial cell marker. All polyclonal antibodies were immuno-
purified on their antigens.
Methods
Wounds Punch biopsies (4 mm diameter) were made in the flanks
of either female adult CD1 rats (200 g, Charles River Laboratory,
Wilmington, Massachusetts) or in the flanks of female adult BALB/
C mice (5–6 wk, Taconic labs, Tarrytown, New York) as described
previously (Brown et al, 1993). Wounds were harvested at intervals,
fixed in 3% paraformaldehyde (pHCHO) in phosphate-buffered
saline (PBS, pH 7.4) for 1 h (41C) or not fixed, quenched in 0.1 M
glycine in PBS, pH 7.4 for 1 h (41C), and sedimented (at unit gravity)
in 0.6% sucrose in PBS, pH 7.4, for 4 h at 41C. The tissues were
embedded in OCT (Electron Microscopy Sciences, Washington,
Pennsylvania) and frozen (801C). Some tissues were frozen im-
mediately after biopsy in OCT, sectioned, and in some instances
post-fixed in acetone (201C). All procedures for animal care and
handling had the approval of the relevant Institutional Animal Care
and Use Committees.
Immunoﬂuorescence Cryostat sections from rat (4 mm) or mouse
(10 mm) were placed on poly-lysine-coated slides and rinsed in
PBS to remove OCT. Fixation protocols used with the respective
antibodies were as follows: BR5.3, IP73, IP264 and 1A4 (pHCHO);
IST-9 (pHCHO or acetone); 1A4, MEC13.3, and rabbit anti-a9
(unfixed). Tissue sections were treated with 5% nonfat milk, 10%
heat-inactivated goat serum and 0.02% Tween 20 in PBS for 1 h
followed successively by diluted primary antibodies, wash buffer
(0.02% Tween 20 in PBS), appropriate fluorescent secondary IgG
in a solution that included phalloidin 488 or 594 (Molecular Probes,
Eugene, Oregon). For anti-EIIIB (IP264), sections were deglycosy-
lated by incubation with PNGase (1:20, New England Biolabs, Be-
verly, Massachusetts) overnight at 371C prior to immunostaining
(Peters and Hynes, 1996; Peters et al, 1996). Controls included
substituting either mouse or rabbit IgG for specific primary antibody.
Rabbit anti-a9 was pre-incubated with peptide, CZ-RKENEDS-
WDWVQKNQ, for 1 h. Photographs were taken under epifluores-
cence illumination on either a Zeiss Axiophot microscope using
Kodak T3200 film or on a Nikon Eclipse TE2000 U using a SPOT
camera (Diagnostic Instruments, Sterling Heights, Michigan).
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